| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |